Literature DB >> 26623073

Investigation of the potential role of preoperative chemotherapy in treatment for gastric cancer with outlet obstruction.

Xuelong Jiao1, Yanbing Zhou1.   

Abstract

Preoperative chemotherapy is currently recognized as the recommended treatment for advanced gastric cancer. Whether there is a role of preoperative chemotherapy in the treatment for advanced gastric cancer with gastric outlet obstruction (GOO) is unknown. In order to explore the potential feasibility of preoperative chemotherapy for advanced gastric cancer with GOO, and to encourage the probe into optimal treatment strategies for advanced gastric cancer with GOO in the current era of preoperative chemotherapy prevailing, a systematic literature search was conducted with a multistage process. The characteristics of the retrieved publications were summarized and the essential information was extracted. Only 11 studies associated with preoperative chemotherapy for advanced gastric cancer with GOO were identified. Among them, 9 were case reports, while the other 2 were research reports of retrospective studies. None were of prospective studies. The paucity of the literature in this field is a marked finding of the present study, which reports the emerging attempts at preoperative chemotherapy for advanced gastric cancer patients with GOO, as no high-quality data are available. The definite role of chemotherapy as an initial treatment for advanced gastric cancer patients with GOO remains unclear. Clinical trials are expected to be conducted in order to explore the feasibility, safety and efficacy of preoperative chemotherapy for advanced gastric cancer patients with GOO.

Entities:  

Keywords:  gastric outlet obstruction; neoadjuvant therapy; nutritional support; preoperative chemotherapy; pyloric stenosis; stomach neoplasm

Year:  2015        PMID： 26623073      PMCID： PMC4534861          DOI： 10.3892/mco.2015.587

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN： 2049-9450


  41 in total

1.  [Two cases of advanced gastric cancer with peritoneal dissemination acquired long-term response three years or more by postoperative treatment with oral anticancer drug TS-1].

Authors:  Toshio Shikano; Katsumi Koshikawa; Kouzou Kiriyama; Masaki Wada; Kenji Taniguchi; Hiroyuki Suenaga
Journal:  Gan To Kagaku Ryoho       Date:  2006-01

2.  Enteral and parenteral nutrition in anorectic patients with advanced gastrointestinal cancer.

Authors:  A Lindh; B Cedermark; H Blomgren; J Wasserman; B Petrini
Journal:  J Surg Oncol       Date:  1986-09       Impact factor: 3.454

3.  [A case of advanced gastric cancer with abdominal para-aortic lymph node metastasis successfully treated with FLP therapy].

Authors:  T Tanabe; A Nashimoto; J Sasaki; M Sano; O Tanaka; M Tsutsui; Y Tsuchiya; H Makino; H Yabusaki; N Akiyama; T Ohta
Journal:  Gan To Kagaku Ryoho       Date:  1999-11

4.  Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer.

Authors:  Roberto Biffi; Nicola Fazio; Fabrizio Luca; Antonio Chiappa; Bruno Andreoni; Maria Giulia Zampino; Arnaud Roth; Jan Christian Schuller; Giancarla Fiori; Franco Orsi; Guido Bonomo; Cristiano Crosta; Olivier Huber
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

5.  A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study).

Authors:  T Yoshikawa; K Omura; O Kobayashi; A Nashimoto; A Takabayashi; T Yamada; H Yamaue; M Fujii; T Yamaguchi; T Nakajima
Journal:  Eur J Surg Oncol       Date:  2010-06       Impact factor: 4.424

Review 6.  Parenteral versus enteral nutrition in cancer patients: indications and practice.

Authors:  S Mercadante
Journal:  Support Care Cancer       Date:  1998-03       Impact factor: 3.603

7.  [A case of advanced gastric cancer showing pylorus stenosis with multiple liver metastases, that respond remarkably to neoadjuvant chemotherapy of combined TXL and low-dose FP].

Authors:  Kanako Sakurai; Atsushi Nashimoto; Hiroshi Yabusaki
Journal:  Gan To Kagaku Ryoho       Date:  2003-03

8.  Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.

Authors:  G Spizzo; D Öfner; A de Vries; P Lukas; G Steger; U Pluschnig; J Zacherl; J Widder; A Zabernigg; G Gastl; G Mühlmann
Journal:  Ann Surg Oncol       Date:  2010-11-10       Impact factor: 5.344

9.  Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.

Authors:  Karen Becker; James D Mueller; Christoph Schulmacher; Katja Ott; Ulrich Fink; Raymonde Busch; Knut Böttcher; J Rüdiger Siewert; Heinz Höfler
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

10.  Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.

Authors:  A Tsuburaya; J Mizusawa; Y Tanaka; N Fukushima; A Nashimoto; M Sasako
Journal:  Br J Surg       Date:  2014-03-25       Impact factor: 6.939
View more
  2 in total

1.  The efficacy and safety of continuous intra-arterial infusion neoadjuvant chemotherapy with surgery for locally advanced gastric cancer: a preliminary pilot study.

Authors:  Bin Li; Rui Tang; Guangqiang Zhang; Jingkai Cheng; Ming Chao; Kefeng Ding
Journal:  J Gastrointest Oncol       Date:  2022-06

2.  The Predictive and Prognostic Factors in Patients with Gastric Cancer Accompanied by Gastric Outlet Obstruction.

Authors:  Hongliang Zu; Huiling Wang; Chunfeng Li; Wendian Zhu; Yingwei Xue
Journal:  Gastroenterol Res Pract       Date:  2020-07-25       Impact factor: 2.260
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.